Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Indivior Pharmaceuticals, Inc. - Common Stock
(NQ:
INDV
)
36.28
UNCHANGED
Delayed Quote
Updated: 4:00 PM EST, Nov 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Indivior Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
Next >
Indivior Reports Third Quarter 2026 Financial Results
October 29, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Report Third Quarter 2026 Financial Results
October 19, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders
September 30, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
September 17, 2026
Payment of Special Dividend Contingent upon Closing of the Pending Merger Transaction
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Halper Sadeh LLC is Investigating Whether INDV, FHB, BGMS are Obtaining Fair Deals for their Shareholders
September 08, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
August 29, 2026
From
Halper Sadeh LLC
Via
Business Wire
Halper Sadeh LLC is Investigating Whether LNTH, ATKR, INDV are Obtaining Fair Deals for their Shareholders
August 03, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
August 03, 2026
From
Halper Sadeh LLC
Via
Business Wire
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
August 03, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 03, 2026
From
Supernus Pharmaceuticals, Inc.; Indivior Pharmaceuticals, Inc.
Via
GlobeNewswire
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
July 23, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
May 20, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Participate in Upcoming Investor Conferences
May 14, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Announces $175 Million Accelerated Share Repurchase
May 04, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
April 30, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
April 24, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
April 16, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
April 09, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
March 31, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
March 17, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Announces Proposed Convertible Senior Notes Offering
March 12, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
March 11, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
January 28, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Announces Completion of Redomiciliation to the United States
January 26, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
January 08, 2026
From
Indivior Inc.
Via
GlobeNewswire
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
October 01, 2024
From
The Schall Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)
September 30, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
